Displaying 101 - 120 of 1624
FTC Submits Comment Supporting Proposed USPTO Terminal Disclaimer Rule
Date
The Federal Trade Commission submitted a comment supporting a proposed U.S. Patent and Trademark Office (USPTO) rule regarding new requirements associated with patent terminal disclaimer practice to...
Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report
Date
By
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
FTC Releases Interim Staff Report on Prescription Drug Middlemen
Date
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and...
Novant Health, Inc. and Community Health Systems, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
231 0068
Docket Number
9425
Case Status
Closed
Statement Regarding the Termination of Novant Health’s Acquisition of Hospitals from Community Health Systems
Date
Federal Trade Commission Bureau of Competition Director Henry Liu issued the following statement in response to Novant Health, Inc.’s decision to terminate its proposed acquisition of two hospitals...
FTC Announces Final Eyeglass Rule Implementing Updates to Promote Competition and Expand Consumer Choice
Date
Concluding a comprehensive multi-year review, the Federal Trade Commission today announced final updates to its Ophthalmic Practice Rules, known as the Eyeglass Rule aimed at promoting competition and...
Federal Register Notice
16 CFR Part 456 Ophthalmic Practice Rule (Eyeglass Rule) - Final Rule - June 2024
Date
FTC Submits Comment Supporting Proposed USPTO Rule
Date
The Federal Trade Commission today submitted a comment supporting a proposed U.S. Patent and Trademark Office (USPTO) rule involving the disclosure of patent settlement agreements. In April, the USPTO...
FTC Releases Fiscal Year 2023 Annual Report
Date
Following Public Service Recognition Week, the Federal Trade Commission released its Fiscal Year 2023 Annual Report outlining the agency’s work to protect consumers and promote competition. “The FTC...
Simple Health Plans LLC
On Oct. 29, 2018, the Federal Trade Commission filed a complaint in federal court against Simple Health Plans LLC, Steven J. Dorfman, and five other entities, alleging that the defendants misled people to think they were buying comprehensive health insurance that would cover preexisting medical conditions, prescription drugs, primary and specialty care treatment, inpatient and emergency hospital care, surgical procedures, and medical and laboratory testing. On Nov. 1, 2019, the FTC filed an amended complaint adding Candida Girouard as an additional defendant.
Type of Action
Federal
Last Updated
FTC Matter/File Number
172 3148
FTC, DOJ, and HHS Extend Comment Period on Cross-Government Inquiry on Impact of Corporate Greed in Health Care
Date
The Federal Trade Commission, the Department of Justice’s (DOJ) Antitrust Division, and the U.S. Department of Health and Human Services (HHS) are extending the deadline by 30 days for the public to...
FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs
Date
Today, the Federal Trade Commission expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book...
Federal Agencies Launch Portal for Public Reporting of Anticompetitive Practices in the Health Care Sector
Date
Today, the Federal Trade Commission, Justice Department, and the U.S. Department of Health and Human Services (HHS) launched an easily accessible online portal for the public to report health care...
Displaying 101 - 120 of 1624